Neurofibromatosis, INC. Midwest
Advocacy and research organization
Based in IL
AI Overview
With $0 in lobbying spend across 32 quarterly filings, Neurofibromatosis, INC. Midwest is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $0 |
| 2019 | $0 |
| 2020 | $0 |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Neurofibromatosis, INC. Midwest disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense, Budget/Appropriations
Department of Defense Appropriations Act, FY2019, Neurofibromatosis provisions
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH
Department of Defense Appropriations Act, FY2019, Neurofibromat
H.R.6157/S.3159, Department of Defense Appropriations Act, FY2019, Neurofibromatosis provisions
H.R.5515/S.2987, National Defense Authorization for Fiscal Year 2019, Monitor medical research issues
S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH
H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH; and Neurofibromatosis provisions
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.